| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/11/2003 | WO2002013874A2 Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses |
| 02/11/2003 | US6519076 Methods and apparatus for optical imaging |
| 02/11/2003 | US6517824 Liposome encapsulated copolymer conjugate; treating pulmonary hypertension and other diseases involving a defect in collagen metabolism; lysine and 4-hydroxyproline dipeptide covalently bound with polyether to form conjugate |
| 02/11/2003 | US6517814 Tetraaza or hexaaza tricylic derivatives or salts containing radionuclide; useful as x-ray or MRI contrast agent |
| 02/11/2003 | US6517813 Contrast medium useful for angiography or lymphography comprising filtering, with a magnetic filter, a suspension of coated magnetic particles whose ratio of relaxivities r2/r1 is greater than 3.2 |
| 02/11/2003 | US6517809 Using a breath test; vehicle containing a sugar is powder or granules, coating vehicle with an isotope-labeled urea and encapsulating the coated vehicle in gelatin |
| 02/11/2003 | US6517513 Intraductal breast fluid aspiration device |
| 02/11/2003 | CA2419223A1 Use of perfluoroalkyl-containing metal complexes as contrast media in mr-imaging for visualization of plaques, tumours and necroses |
| 02/11/2003 | CA2152667C Bone resorption assay |
| 02/07/2003 | WO2002014309A1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof |
| 02/07/2003 | CA2418790A1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof |
| 02/06/2003 | WO2003010281A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 02/06/2003 | WO2003010199A2 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
| 02/06/2003 | WO2003010198A1 Identification of specific tumour antigens by selection of cdna libraries with sera and use of said antigens in diagnostic techniques |
| 02/06/2003 | WO2003009874A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules |
| 02/06/2003 | WO2003009842A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 02/06/2003 | WO2003009804A2 Conformationally constrained parathyroid hormone (pth) analogs |
| 02/06/2003 | WO2002040061A9 Immunocompetent animals including xenogeneic implants of mesenchymal stem cells |
| 02/06/2003 | WO2002039112A3 In vivo detection of biomolecule concentrations using fluorescent tags |
| 02/06/2003 | WO2002021996A3 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 02/06/2003 | WO2002020722A3 Methods and compositions for in vitro targeting |
| 02/06/2003 | WO2001064874A9 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/06/2003 | US20030028101 Systems and methods for targeted magnetic resonance imaging of the vascular system |
| 02/06/2003 | US20030026850 Penetration of blood, brain barrier; transdermal drug delivery; mixing with dinitroamide compound |
| 02/06/2003 | US20030026834 Analgesics |
| 02/06/2003 | US20030026764 Administering antibodies; anticancer agents |
| 02/06/2003 | US20030026763 Using water soluble dyes |
| 02/06/2003 | US20030026762 Bio-spectral imaging system and methods for diagnosing cell disease state |
| 02/06/2003 | US20030026761 Diagnosis of skin disorders |
| 02/06/2003 | US20030026760 Methods of determining the effects of toxins |
| 02/06/2003 | CA2455602A1 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 02/06/2003 | CA2454784A1 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
| 02/06/2003 | CA2454150A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 02/06/2003 | CA2453106A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules |
| 02/05/2003 | EP1281772A1 Light-emitting microorganisms and cells for tumour diagnosis/therapy |
| 02/05/2003 | EP1281767A2 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 02/05/2003 | EP1281405A2 Short-chained peptide-dye conjugates as contrast agents for optical diagnosis |
| 02/05/2003 | EP1281085A1 Dynamic superparamagnetic markers |
| 02/05/2003 | EP1037671B1 Polyrotaxanes |
| 02/05/2003 | EP0928611B1 Medical powder |
| 02/05/2003 | EP0730616B1 Process for preparing polyazamacrocycles |
| 02/05/2003 | CN1394649A Ending vascular embolism preparation |
| 02/05/2003 | CN1100767C Macrocyclic metal complex carboxylic acids, use and method for production thereof |
| 02/04/2003 | US6515113 Phthalamide lanthanide complexes for use as luminescent markers |
| 02/04/2003 | US6514480 Method for producing contrast agents largely free of side-effects |
| 02/04/2003 | US6514209 Method of enhancing ultrasonic techniques via measurement of ultraharmonic signals |
| 02/04/2003 | US6514193 Method of administering a therapeutically active substance |
| 01/30/2003 | WO2003008394A1 Novel chelating agents and conjugates thereof, their synthesis and use as diagnostic and therapeutic agents |
| 01/30/2003 | WO2003008390A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 01/30/2003 | WO2003008186A1 Insulating and functionalizing fine metal-containing particles with comformal ultra-thin films |
| 01/30/2003 | WO2002007773A3 Multi-component biological transport systems |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | WO2001090359A3 G-protein coupled receptors |
| 01/30/2003 | WO2001015743A8 Viscosity-standardised compositions which facilitate swallowing in dysphagic subjects |
| 01/30/2003 | US20030022926 Method for treating neuropathic pain and pharmaceutical preparation therefor |
| 01/30/2003 | US20030022869 For blocking prenylation transferase enzymes; anticancer agents; stability |
| 01/30/2003 | US20030022813 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 01/30/2003 | US20030022812 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 01/30/2003 | US20030022349 Virulence-associated nucleic acid sequences and uses thereof |
| 01/30/2003 | US20030022198 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 01/30/2003 | US20030022105 Two -photon upconverting dyes and applications |
| 01/30/2003 | US20030021750 Novel functional agents for magnetic resonance imaging |
| 01/29/2003 | EP1279912A2 Methods of collecting and thawing polarised gases, associated accumulators and heating jackets |
| 01/29/2003 | EP1278766A2 Polynucleotides for diagnosing mammary gland cancer |
| 01/29/2003 | EP1278553A2 Magnetic resonance imaging agents for the delivery of therapeutic agents |
| 01/29/2003 | EP1278552A2 Functional mri agents for cancer imaging |
| 01/29/2003 | EP1278512A2 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 01/29/2003 | CN1099869C Photosensibilizers |
| 01/28/2003 | US6512161 Genomic DNA sequences that encode apolipoprotein (A) and apolipoprotein B polypeptides |
| 01/28/2003 | US6511649 Vitronectin receptor antagonist pharmaceuticals |
| 01/28/2003 | US6511648 Vitronectin receptor antagonist pharmaceuticals |
| 01/28/2003 | CA2254905C Tricyclic functional dyes for contrast enhancement in optical imaging |
| 01/28/2003 | CA2158425C Diagnostic and treatment of erectile dysfunction |
| 01/28/2003 | CA2027714C Method of measurement in biological systems |
| 01/23/2003 | WO2003006625A2 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 01/23/2003 | WO2003006491A2 Peptide-based compounds for targeting intergin receptors |
| 01/23/2003 | WO2003006371A1 N,n-dinitramide salts as solubilizing agents for biologically active agents |
| 01/23/2003 | WO2003006071A1 Infection control system |
| 01/23/2003 | WO2003006070A2 Improved chelator conjugates |
| 01/23/2003 | WO2003006069A1 Imaging infection using fluorescent protein as a marker |
| 01/23/2003 | WO2003006025A1 Methods and materials for treating bone conditions |
| 01/23/2003 | WO2002016939A3 Methods of diagnosis of cancer and screening for cancer modulators |
| 01/23/2003 | WO2002013876A3 Tissue marking using biocompatible microparticles |
| 01/23/2003 | WO2001070102A3 Meted hyperpolarized noble gas dispensing methods and associated devices |
| 01/23/2003 | US20030017617 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | US20030017612 Methods and reagents to acquire MRI signals and images |
| 01/23/2003 | US20030017479 Methods for the detection, treatment, and prevention of neurodegeneration |
| 01/23/2003 | US20030017468 Nucleotide sequences which code lung preferential gene for use in the treatment and diagnosis of lung cancer |
| 01/23/2003 | US20030017456 Diagnosis and treatment and related preparations |
| 01/23/2003 | US20030017112 Porphyrin compounds |
| 01/23/2003 | US20030017111 Fluorescent agents for real-time measurement of organ function |
| 01/23/2003 | US20030017110 Enhancement of NMR and MRI in the presence of hyperpolarized noble gases |
| 01/23/2003 | US20030017109 Mixable combination for generating a suspension of stable microbubbles for ultrasonic imaging |
| 01/23/2003 | CA2453179A1 N,n-dinitramide salts as solubilizing agents for biologically active agents |
| 01/23/2003 | CA2452876A1 Imaging infection using fluorescent protein as a marker |
| 01/23/2003 | CA2451109A1 Infection control system |
| 01/22/2003 | EP1277728A1 Novel TTDA derivatives and their use as gadolinium chelators for MRI imaging |
| 01/22/2003 | EP1277470A1 Injectable galenical formulation for use in photodynamic diagnostic or therapy and process of manufacturing it |
| 01/22/2003 | EP1276770A1 Proteins with a high immunoreactivity and a method for the production thereof |
| 01/22/2003 | EP0901491B1 Tropane derivatives useable in particular for in vivo detection of dopamine transporters |